Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCTD8 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | MLLT1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
mRNA | HEATR5B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | ATP5EP2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
mRNA | RPRM | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | RAB40B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | HMX3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | HILPDA | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
mRNA | MTRNR2L3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
mRNA | ABCA13 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |